We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

LakeShore Biopharma Co Ltd (LSB) USD0.0001

Sell:$0.40 Buy:$0.49 Change: $0.043 (9.84%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$0.40
Buy:$0.49
Change: $0.043 (9.84%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$0.40
Buy:$0.49
Change: $0.043 (9.84%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.

Contact details

Address:
BEIJING
102629
China
Telephone:
+86 (10) 89202086
Website:
https://www.ysbiopharm.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LSB
ISIN:
KYG9845F1090
Market cap:
$83.69 million
Shares in issue:
188.33 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
Cayman Islands
Currency:
US dollar
Indices:
n/a

Key personnel

  • Yi Zhang
    Chairman of the Board
  • Hui Shao
    President, Co-Chief Executive Officer, Director, Chief Business Officer
  • Dave Chenn
    Interim Co-Chief Executive Officer, Director
  • Chunyuan Wu
    Chief Financial Officer
  • Gang Li
    Head of Marketing and sales
  • Yuan Liu
    Head of vaccine research
  • Zenaida Mojares
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.